Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,377–2,384 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Kazia Therapeutics Limited Paxalisib - (A071701) Brain Metastases Phase 2 Data Released Oral Oncology
Kazia Therapeutics Limited Paxalisib with Metformin Glioblastoma Phase 2 Oral Oncology
Kazia Therapeutics Limited Paxalisib (PNOC022) Diffuse intrinsic pontine glioma (DIPG) and diffuse midline gliomas (DMGs). Phase 2 Data Released Oral Oncology
Kazia Therapeutics Limited Cantrixil Ovarian cancer Phase 2 Intraperitoneal Oncology
Kazia Therapeutics Limited Paxalisib (GDC-0084) with trastuzumab Breast cancer brain metastases Phase 2 Oral with intravenous Oncology
Kazia Therapeutics Limited Paxalisib - (A071701) Brain Metastases Phase 2 Data Released Oral Oncology
Kazia Therapeutics Limited Paxalisib with Metformin Glioblastoma Phase 2 Oral Oncology
Kazia Therapeutics Limited Paxalisib (PNOC022) Diffuse intrinsic pontine glioma (DIPG) and diffuse midline gliomas (DMGs). Phase 2 Data Released Oral Oncology